Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AstraZeneca ADR Representing 0.5 Ord Shs AZN

Consumer Cyclical Healthcare Advertising Agencies
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AZN)

CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial

Business Wire 1 day ago

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

Business Wire 2 days ago

ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow

Business Wire 4 days ago

Q1 2024 results

Business Wire 8 days ago

IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial

Business Wire April 16, 2024

FASENRA approved for treatment of children aged 6 to 11 with severe asthma

Business Wire April 11, 2024

ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors

Business Wire April 5, 2024

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors

Business Wire April 5, 2024

IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

Business Wire April 5, 2024
View More News ››

Opinion & Analysis (NDAQ:AZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AZN)

Datopotamab Deruxtecan Biologics License Application Accepte

Just In: $AZN Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced...
whytestocks - February 19, 2024

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

Breaking News: $AZN AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript2024-02-08 16:15:30 ET Image source: The Motley Fool...
whytestocks - February 8, 2024

Hospital Infection Therapeutics Market Size & Share 2021-26

According to IMARC Group’s latest report, titled “Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth...
edwardebreen15 - August 22, 2022

Aztra vaccine coming to Canada soon news?

https://www.msn.com/en-ca/news/newspolitics/health-canada-to-decide-on-astrazeneca-covid-19-vaccine-in-coming-days/ar-BB1ddoDT?ocid...
Rejean1 - January 29, 2021

Conflicting news???

I thought I just read elsewhere they had banned shots to people over 65? A month after it received approval in the UK, the EU’s...
Rejean1 - January 29, 2021

5 dead in Astrazeneca fire in India.

https://www.bbc.com/news/world-asia-india-55753586
Rejean1 - January 21, 2021
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »